cro.directory
← Compare landing

Accelera Srl vs Cardiomedex

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/accelera/cardiomedex

CategoryAccelera SrlCardiomedex
Listed sitecrocro
SummaryEurope-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.
Services
  • GLP Toxicology
  • DART (Reproductive & Developmental Toxicology)
  • Safety Pharmacology
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Translational Research
  • Regulatory Affairs
  • Cardiovascular & Metabolic Specialty Services
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Other)
  • Small Molecule
Indications
  • Oncology
  • Cardiovascular
  • Metabolic
Locations
  • Headquarters, Milan, Italy
  • Headquarters, Toulouse, France
Certifications
  • AAALAC · Identifier: AAALAC accreditation
  • GLP · Identifier: GLP compliance
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.